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Elderly healthy individuals have a reduced exercise tolerance and a decreased left
ventricle inotropic reserve related to increased vascular afterload, arterial-ventricular load
mismatching, physical deconditioning and impaired autonomic regulation (the so called
“β-adrenergic desensitization”). Adrenergic responsiveness is altered with aging and the
age-related changes are limited to the β-adrenergic receptor density reduction and to
the β-adrenoceptor-G-protein(s)-adenylyl cyclase system abnormalities, while the type
and level of abnormalities change with species and tissues. Epidemiological studies
have shown an high incidence and prevalence of heart failure in the elderly and a
great body of evidence correlate the changes of β-adrenergic system with heart failure
pathogenesis. In particular it is well known that: (a) levels of cathecolamines are directly
correlated with mortality and functional status in heart failure, (b) β1-adrenergic receptor
subtype is down-regulated in heart failure, (c) heart failure-dependent cardiac adrenergic
responsiveness reduction is related to changes in G proteins activity. In this review we
focus on the cardiovascular β-adrenergic changes involvement in the aging process and on
similarities and differences between aging heart and heart failure.
Keywords: β-adrenergic receptors, β-adrenoceptor desensitization, β-adrenoceptor down-regulation, G-protein
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INTRODUCTION
Epidemiological studies reveal an high incidence and prevalence
of heart failure in the elderly (Roger et al., 2011). In chronic heart
failure substantial and characteristic changes occur in the cardiac
structure and function and these modifications are not very dif-
ferent from those observed in the aging heart (Shioi and Inuzuka,
2012). The peculiar age-related cardiac structural changes are
represented by an increase in cardiomyocyte size and in myocar-
dial thickness (Scholtz et al., 1988; Olivetti et al., 1991), which
are able to affect the contractile efficiency of the left ventri-
cle. These changes are associated with increased cardiac fibrosis
and vascular stiffening. However, epidemiological and autopsy-
based studies, performed in subjects free from coronary artery
disease and hypertension, have demonstrated no significant age-
related changes in cardiac mass in elderly female and a decrease
in left ventricular mass in elderly male compared to young male
(Hess et al., 2002; Khouri et al., 2005) (“cardiac sarcopenia”).
Nevertheless, ageing is not associated with impaired systolic car-
diac function at rest, as demonstrated by echocardiographic and
radionuclide studies performed in normotensive healthy subjects
(Khouri et al., 2005). Differently, ageing is related to diastolic
left ventricle function with increased prevalence of diastolic heart
failure. It is well known that in healthy elderly there is a reduc-
tion in left ventricle inotropic reserve and exercise tolerance.
Reduced inotropic cardiac reserve is thought to be related to
increased vascular afterload, arterial-ventricular load mismatch-
ing, physical deconditioning and impaired autonomic regulation
(so called “β-adrenergic desensitization”). It is interesting to point
out the similarity observed in terms of hemodynamic profile
under adrenergic challenge between younger β-blocked subjects
and healthy elderly subjects without β-blocker treatment (Fleg
et al., 1994). Adrenergic receptors activation by catecholamines
is the most important regulatory mechanism of cardiovascular
performance. Adrenergic receptor agonists, as well as exercise,
stimulate the adrenergic system increasing heart rate, myocardial
contractility and relaxation, reducing left ventricular afterload
and redistributing blood flow to skeletal muscle. Anyway, adren-
ergic responsiveness is altered with aging (White et al., 1994).
In fact, both animal and human studies indicate a decline in
heart rate, cardiac contractility, cardiac output and ejection frac-
tion in response to β-adrenergic stimulation and exercise (Rinaldi
et al., 2006; Corbi et al., 2012a,b). Part of the age-related decline
in β-adrenergic responsiveness has been attributed to a general
decrease in cardiac contractility. However, several observations
indicate a crucial role of reduced β-adrenergic receptor density
and some defects involving the adenylyl cyclase cascade beyond
β-receptor levels (Ferrara et al., 1995, 2005; Freedman et al.,
1995). The age-associated reduction in maximal heart rate dur-
ing high levels of exercise are in relationship with a reduced
β-adrenergic responsivity despite an increase in circulating levels
of catecholamines (Corbi et al., 2013a). Aging is associated with
elevated neuro-hormonal activation, and characterized by ele-
vated plasma norepinephrine and epinephrine circulating levels,
due to increased spillover from tissues (including the heart) and
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reduced plasma clearance of catecholamine (Ng et al., 1993; Esler
et al., 1995). The “β-adrenergic desensitization,” at least in part, is
due to the reduction of β-adrenergic receptor plasma membrane
density described in hearts of both senescent animals and elderly
humans (White et al., 1994; Xiao et al., 1998). The β-adrenergic
receptors are members of the G-protein-coupled receptor family,
which acts by coupling with guanine nucleotide binding proteins,
and the age-induced decrease in β-adrenoceptor responsiveness
is characterized at the molecular level by decreased activation
of adenylyl cyclase and reduced production of cAMP. Beside β-
adrenergic receptor down-regulation, another crucial age-related
alteration of this signaling pathway seems to be the coupling of the
β-adrenergic receptor to adenylyl cyclase via the Gs protein, which
leads to a reduction in the ability to increase cAMP and to activate
protein kinases. Some studies have also reported an increase in
Gαi activity as a possible additional mechanism in “β-adrenergic
desensitization.”Moreover, the reduction in the efficacy of cardiac
β-adrenoceptor stimulation with aging could be also related to
othermechanisms, such as the upregulation of G protein–coupled
receptor kinases (Rengo et al., 2012a), whereas the role of these
kinases in aging heart is controversial. From an overall data anal-
ysis on the role of aging in β-adrenoceptor regulation in human
and animal hearts it is possible to conclude that the reduced
response to β-agonists is common to all species and all cardiac
tissues investigated. Moreover, the age-related changes are limited
to β-adrenoceptor-G-protein (s)-adenylyl cyclase system abnor-
malities, while the type and level of abnormalities change with
species and tissues. These differences could explain the incon-
sistency in results obtained in different experimental models of
aged heart. Interestingly, several evidence suggest that the β-
adrenergic receptor system plays an important role also in heart
failure pathogenesis. In fact, it is well known that (a) the levels of
cathecolamines are directly correlated with mortality and func-
tional status in heart failure, (b) cardiac β-receptors, in particular
β1 subtype, are downregulated in heart failure and (c) heart
failure-dependent cardiac adrenergic responsiveness reduction is
related to adrenoreceptor kinases and Gαi increased activities.
AIMS
This review focuses on (a) the development of knowledge
on aging heart over the years, (b) the changes involving the
sympathetic system in relationship to the cardiovascular aging
in different species, (c) the clinical implications of changes in
β-adrenergic mechanisms in the aging heart and d) the similarity
between aging and failing heart.
β-ADRENERGIC SIGNALING IN THE HEART AT MOLECULAR
LEVEL
For the first time the existence of β-adrenergic receptors (β-
AR) was described in 1948 by Alquist (1948). At the present
three subtypes of β-AR: β1-AR, β2-AR, β3-AR have been recog-
nized. A fourth subtype has been proposed and investigations
have been recently clarified its functioning and localization (Lewis
et al., 2004). At the beginning it was thought that only β1-
AR subtype was expressed in the cardiac cells. However, many
studies provided evidence that both heart β1-AR subtype and
β2-AR subtype (Lemoine and Kaumann, 1991; Altschuld et al.,
1995; Lonardo et al., 2005), coexist in humans as well as in
animals. In the human heart approximately 80% of the β-AR
subtype expressed belong to the β1-AR, followed by 20% of
the β2-AR subtype (Lakatta and Levy, 2003). It is important
to underline that this β-AR expression proportion has been
observed in the non-failing young, but not in elderly human
heart.
Modern molecular biology techniques and radio-ligand bind-
ing studies have shown that major expression and main con-
tribution in the contractile functioning of cardiac cells belong
to the β1-AR subtype (Benovic et al., 1991; Borea et al., 1992).
In humans, as well as in other animals with relative big body
weight like sheep, dogs or cats, the β1-AR and β2-AR are both
significantly present, while in other small animals like rats or
guinea-pigs the presence of β2-AR is undetectable. Some other
studies found the presence of β2-AR in rat hearts but not localized
in ventricular myocytes (Buxton and Bruton, 1985). Even the dif-
ferent specie-dependent contribution of β-AR and the difficulties
to find a perfect experimental model, it is well known that in all
different species the general mechanical pathway is always related
to adenylyl cyclase (AC) activation, cyclic AMP (c-AMP) forma-
tion, Protein Kinase A (PKA) activation and G-Protein Coupled
Receptor Kinase (GRK) activation. β-AR are members of the
G-Protein Coupled Receptors (GPCRs) family which acts by cou-
pling with Guanine nucleotide binding proteins (Rengo et al.,
2012a). β1-AR subtype is coupled to the stimulatory G protein
(Gs). Gs protein is a heterotrimetric protein made up of α, β, and
γ subunits. The presence of β-AR agonists induces the dissocia-
tion of Gs protein in two subunits: α subunit and β-γ subunit.
The primary effect of this dissociation is the activation of AC that
catalyzes the conversion of ATP to c-AMP, a second intracellular
messenger, and induces the activation of c-AMP dependent PKA.
Serine and threonine residues of many regulatory proteins are
phosphorylated by PKA. These regulatory proteins include: β-AR
themselves, myofilament proteins (troponine I and C protein),
membrane proteins (phospholamban—PLB, L-type Ca++ chan-
nels, Sarcoplasmatic Reticulum—SR, Ca++/ATPase inhibitory
protein). The stimulation of β-AR modifies not only the car-
diac excitation and contraction but also other cellular functions
such as gene transcription and growth, and can induce death.
An important role for the above mentioned functions has played
by the activation of Mitogenic-Activated Protein Kinase (MAPK).
Moreover, these kinases are thought to be implicated in the regu-
lation of several vital cellular processes, including differentiation,
proliferation, growth, and death (Van Biesen et al., 1995). Ultra
Violet light, osmotic stress and heat shock can activate MAPK sig-
naling cascades and GPCRs play a pivotal role in the regulation of
MAPKs, particularly of the extracellular signal-regulated kinase
(ERK1/2) MAPK. One major pathway of GPCRs-mediated acti-
vation of MAPKs is dependent on “transactivation” of a group
of receptor tyrosine kinases, such as epidermal growth factor
and insulin-like growth factor. Additionally the activation of p38
MAPK, also called “stress-activated protein kinase,” is associ-
ated with the initial signs of cardiac hypertrophy in response
to “in vivo” pressure overload or ischemic/reperfusion injury
(Bogoyevitch et al., 1996; Wang et al., 2013).
The β-AR stimulation induced by catecholamines is also
responsible for the Ca++ influx, that by itself triggers a potential
release of Ca++ from SR, acting on the ryanodine receptors.
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The intracellular Ca++ release activates contractile proteins,
finalizing the muscular contraction (positive inotropic effect).
Then, intracellular Ca++ is removed from the cytoplasm by
the SR-Ca++/ATPase pump and the Na+/Ca++ exchange. The
further acceleration of Ca++ removing leads to the muscle relax-
ation. The maximum velocity of relaxation is defined as positive
lusitropic effect. As a result of PKA activation, the β-AR stimula-
tion triggers the G-Protein Coupled Receptor Kinase family, like
GRK2. GRKs are a family of serine/threonine protein kinases that
phosphorylates GPCRs only when the receptors are in the acti-
vated (agonist-bound) state. When β-ARs are stimulated by ago-
nists, the β-γ subunits G interact with GRK2 bringing the kinase
from the intracellular to the transmembranic localization, phos-
phorylating the β-ARs, becoming target for binding of β-Arrestin
proteins. The β-Arrestin bounds to these receptors and prevents
their further coupling to the G-protein, reducing the level of
functional receptors, inducing the internalization of receptors
and, as final result, their decreased density and desensitization
(Freedman et al., 1995).
“In vitro” studies showed further mechanisms induced by
stimulation of β1-AR. For example, persistent stimulation of
β1-AR is able to activate Calmoduline Dipendent Kinase II,
without the implication of PKA pathway. This mechanism
induces cardiomyocyte hypertrophy and could explain the well-
known relationship between adrenergic stimulation and cardiac
hypertrophy23-24 (Ramirez et al., 1997; Morisco et al., 2000). In
addition to the cardiac effects, β1-ARs regulate the release of
renin, the activation of Renin-Angiotensine-Aldosteron (RAA)-
system and the lipolysis.
β2-AR, one of the first receptors identified, belongs to the
GPCRs family and plays an important role in the cardiovascular
and respiratory physiology. Its main effects are related to vasodi-
latation and bronchodilatation (Corbi et al., 2013b). In addition
β2-AR is responsible for glycogenolysis (Corbi et al., 2002) and
relaxation of uterine muscle. Despite similarities β1-AR and β2-
AR present different signaling pathways. The β2-AR is coupled to
the Gs protein and to the Gi protein too (dual coupling of β2AR to
Gs and Gi protein). There is also evidence that β2-AR signaling is
coupled to an independent pathway like the Na+/H+ exchanged
regulatory factor (Hall et al., 1998).
The effects of β2-AR Gs stimulation are not identical to them
obtained from β1-AR stimulation. However, similarly to β1-AR,
β2-AR-Gs stimulation increases the c-AMP and PKA activity.
Recent studies have demonstrated that the effect of β2-AR c-
AMP/PKA stimulation is limited to the subsurface membrane of
the L-type Ca++ channels without cellular signal transmission.
As a result of this mechanism it is observed a positive inotropic
effect without influence on the intracellular Ca++ transient decay
time, changes in myofilaments sensitivity to Ca++ and increase
SR Ca++ uptake. Obviously β2-AR stimulation does not affect the
relaxation time (lusitropic effect) as β1-AR does (Kuschel et al.,
1999; Xiao et al., 1999).
Surprisingly the Ca++ influx, the PKA and the c-AMP lev-
els apparently do not show significant association after β2-AR
stimulation in studies using adult rat and canine models. Even
if the reason of this dissociation remains unclear, the role of c-
AMP modulation in the contractility of cardiac muscle is well
established. In heart animal models forskolin induces c-AMP lev-
els augmentation increasing the inotropic effect. Moreover, it has
well demonstrated that the Ca++ influx mechanism is exclusively
mediated by c-AMP pathway (Xiao et al., 1994).
On the other hand, the Gαi protein subunit inhibits the adenyl-
cyclase enzyme activity. The β2-AR Gi signaling inhibits the
c-AMP synthesis and has negative effects on the PKA activation.
Persistent activation of β2-AR-Gβ−γi signaling activates in turn
the phosphoinositol3- Kinase (PI3-K), an important downstream
messenger that triggers the antiapoptotic factor Akt and seems
to have a cardioprotective role. (Zhu et al., 2001; Cannavo et al.,
2013).
The model of β2-AR dual coupling of to multiple G pro-
tein (Gi and Gs protein), is not well clarified. Several evidence
indicate that β2-AR–Gi signaling compartmentalizes the β2-AR-
Gs–c-AMP signaling. Disrupting the Gi functioning by a potent
Gi inhibitor like Pertussis Toxine (PTX) induces an enhance in
the phosphorylation of PLB and an increased inotropic effect
after β2-AR stimulation. In this occasion the β2-AR signaling is
comparative to the β1-AR signaling31 (Xiao et al., 1995).
The β2-AR phosphorylation by PKA and GRK2 switches the
β2-AR receptor coupling from Gs to Gi. As demonstrated in sev-
eral studies, the β2-AR-Gi coupling is suppressed after GRK2
activity inhibition. In a near future, it may be possible to prevent
important structural changes, like myocardial stiffness, reactive
fibrosis and remodeling present in the aging and failing heart,
modifying the GRK2 and the Gi activated or inhibited status.
Another candidate mechanism, underling the compartmen-
talization of β2-AR–Gs-c-AMP-PKA signaling in response to the
β2-AR-Gi coupling, is the structural restriction of PKA diffusion
by muscle specific protein A kinase anchory proteins (AKAP)
(Enns et al., 2009). The phosphorylation of AKAP plays mul-
tiple roles including: ions influx, contraction, transcription of
different genes, phosphorylation of multiple intracellular targets
in cardiac myocytes including the L-type Ca++ channel in the
sarcolemma, the ryanodine receptor (RyR2), and phospholam-
ban in the SR. Deficiencies in this pathway have been linked
to cardiomyopathy in humans, due to reduced phosphorylation
of downstream targets such as cardiac troponin (McConnachie
et al., 2006). Moreover, in genetically manipulated models it is
obtained an increased positive inotropic effect after disrupting
the APAK kinase anchory protein (Marshall, 1995; Spindler et al.,
2013).
AGE-INDUCED CHANGES IN THE β-AR SIGNALING
Adrenergic signaling is a very important for cardiovascular
physiology. In conditions involving physical or psychological
stress high levels of cathecolamines like norepinephrine and
epinephrine are released from the adrenal medulla. It is well
known that the action of cathecolamines is mediated by adren-
ergic receptors and the effects on cardiovascular system include:
increased heart rate and myocardial contractility force and relax-
ation, increased cardiac output, reduced left ventricular afterload,
a diversion of blood flow from the skin and splanchnic ves-
sels to those supplying skeletal muscles, bronchial dilatation and
a decline in metabolic activity (Young and Landsberg, 1998).
Generally the age-related decrease in β-adrenoceptor response has
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been explained by a mechanism called “β-adrenoceptor desensi-
tization.” It is a process characterized by β-ARmolecular changes:
phosphorylation of receptor structures enhanced by an agonist-
receptor bind state, that induces the reduction of receptors den-
sity and their internalization. This process is well-described also
in the heart failure (Rengo et al., 2012a). By aging a post-synaptic
“β-adrenoceptor desensitization” responsible for a reduction in
the autonomic modulation of the cardiac system, especially dur-
ing physical exercise (Ehsani, 1987; Scarpace et al., 1994), is
observed. During exercise the stroke volume increase is similar
in young and older, but the mechanism of this increase is differ-
ent. The elderly tends to augment stroke volume more through
cardiac dilatation with an end-diastolic volume increase, while
the young shows an increase in the ejection fraction without car-
diac dilatation. Moreover, during exercise the older has a lower
increase in heart rate and a greater raise in blood pressure (Ferrara
et al., 2006; Corbi et al., 2012b). In particular in the aging human
heart the maintaining of cardiac output during exercise is sup-
ported more heavily by the Franck-Starling mechanism and less
by sympathetic stimulation demonstrating the presence of an
age-related change in the adrenergic modulation. It is interest-
ing to point out the similarity observed in terms of hemodynamic
profile between younger β-blocked subjects and healthy elderly
without β-blockers treatment in humanmodels without HF (Fleg
et al., 1994). Younger β-blocked subjects showed during exercise
reduced heart rate and contractility index, and increased left ven-
tricular volume, in short terms they apparently “looked older”
but the results of β-AR blockade were greater in the young sub-
jects compared to older ones, suggesting that β-AR responsiveness
reduces with aging.
Interestingly, Leosco et al. (2007) demonstrated that exercise
training alone as well as metoprolol alone or in combined ther-
apy (exercise + metoprolol) improved the β-AR signaling in
the aged heart suggesting a similar effect on β-AR signaling of
chronic treatment with β-blockers and chronic exercise training.
Furthermore they found an increased β-AR density inducing a
reversible level of β-AR desensitization. The overall reduction in
cardiac reserve is responsible for the decreased exercise tolerance
and for the impairment in cardiac response at exercise in terms
of reduced ejection fraction at peak and heart rate responsiveness
during dynamic exercise. The responsibility of this response could
be related to increased vascular afterload, arterial-ventricular load
mismatching, reduced intrinsic myocardial contractility, physi-
cal deconditioning and impaired autonomic regulation (so called
“β-adrenergic desensitization”). The mechanism of this impaired
autonomic regulation induced by age is not completely clarified,
although it is hypothesized that the increase in cathecolamines
levels plays an important role in the “β-adrenergic desensitiza-
tion” in aging and failing heart. In both conditions, as a result of
a reduced plasma clearance and an increased spillover from the
tissues, the level of circulating cathecolamines further rises. This
prolonged cathecolamines action seems to be also related to the
age-dependent reduction of the cathecolamines re-uptake trans-
porter localized in the sympathetic nerve terminals (Leineweber
et al., 2002). However, controversial opinions exist in the present
literature about the changes in the systemic norepinephrine levels
with age and the relationship between the age-related increased
levels of cathecolamines and the suggested mechanisms of age-
related “β-adrenergic desensitization” (Folkow and Svanborg,
1993; Esler et al., 1995).
The age-related “β-adrenergic desensitization,” a possible
adaptive mechanism, has been observed in both animals and
humans. An age-related effect on the maximum contractility
response to isoproterenol has been demonstrated in arterially
perfused interventricular septa from adult and senescent rats
(Froehlich et al., 1978), and a reduced inotropic response of aged
myocardium to catecholamines has been found in superfused tra-
beculae (Jiang et al., 1993). At molecular level, in particular, the
decrease in β-adrenoceptor responsiveness has been related to
changes in G-proteins and kinases activity even if differences in
the level and extent of these changes exist among different species.
Concerning the β-AR density, the first studies performed in cir-
culating lymphocytes did not show any important age-related
changes in β-AR density (Abrass and Scapace, 1981; Landmann
et al., 1981). Also other data obtained from young and old rats
did not report any changes in β-AR number (Bohm et al., 1993)
did not find any changes in β-AR number but noticed a Gi
increased content. This study hypothesized that Giα might serve
as a age-related regulator of cardiac AC activity in the absence
of β-adrenoceptor changes. Interestingly Gudmundsdottir et al.
(1991) showed that dietary fat and age modified the density of
Ca++ channels and reduced the β -AR number in the rats.
Cerbai et al. (1995) confirmed that β2-AR as well as β1-AR are
both functionally present in rat hearts, but only the β1-AR density
was reduced with aging. In human aging heart White et al. (1994)
found that the β1-AR down regulation mechanism was linked to
the reduced number of β1-AR in a high affinity agonist binding
state. In our experience, using a model of myocytes obtained from
human failing (donors) and non-failing hearts (small biopsies
from elderly and young patients undergoing coronary vein graft
with preserve ventricular function), the contractile response to β-
adrenoceptor stimulation has been found to be strongly reduced
in single myocytes from failing human ventricle, but a part of
this reduction was statistically related to the patient’s age (Dobson
et al., 1990; Davies et al., 1996). At beginning, it was thought that
the desensitization mechanism of β-AR in the elderly is related to
the increased levels of adenosine because its clear antiadrenergic
action in the heart, as suggested by studies performed in guinea
pig aging hearts. However, utilizing single isolated left ventricu-
lar cardiac myocytes from hearts of animals at different age, other
studies showed that the age-related contractility impairment dur-
ing β-adrenergic stimulation was confined to the β-adrenergic
pathway with reduced net production of c-AMP, that could not be
explained by the increased adenosine stimulation (Ferrara et al.,
1995).
Ferrara et al. (1995), in a study performed on myocytes iso-
lated from the young and old guinea-pigs, observed that there was
a pronounced age-related decrease in contractility of myocytes
after both isoproterenol and high Ca++ concentration stimula-
tion. However, the Ca++ influence was less significant conclud-
ing that a general diminished contractility of single myocytes
occurs during the physiological aging and these effects were
more marked for β-AR stimulation than for high Ca++, sug-
gesting a specific lesion in the AC related pathway. In a further
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investigation, using the same experimental model, the same
authors (Ferrara et al., 1997a) studied the role of the inhibitory G-
proteins (Gi) in the decline of contractility related to β-stimulated
activity. In these experiments they found that β-AR number was
decreased by 27% in senescent animals and the Giα activity,
detected by PTX-catalyzed ADP ribosylation, was significantly
increased in aged animals, while immunodetectable level of Giα
was not modified. The authors concluded that increased Giα
activity contributes significantly to the decreased response to
β-AR stimulation in myocytes in aged guinea-pigs.
In different species (rats) Xiao et al. (1998) found a clear age-
related reduction in contractility in response to β-AR subtype
stimulation associated to a non-selective decrease in the density of
both β-AR subtypes and a reduction in membrane AC response
to either β1-AR or β2-AR stimulation. Moreover, the activity of
β-AR kinase GRK5, and of Gi did not significantly change with
aging, suggesting that the marked decreased response to β-ARs
stimulation with aging in rat ventricular myocytes was linked
to a decrease in both β-AR subtypes densities and a reduction
in membrane AC activity, while neither GRKs nor Gi proteins
appear to play a role in this mechanism. This apparent contrast
with the results from Ferrara et al. (1997a) could be referred to
the different animal models used for the experiments.
As in the failing heart, the role of chronic sympathetic drive in
the β-AR desensitization in the aging heart can be hypothesized.
Because the role of GRKs in the aging heart could be defined con-
troversial same studies have been planned to focus on the role of
GRKs in the aged cardiovascular system.
Schutzer et al. (2001) examined the correlation of GRKs level
to age-related modifications in aorta of old rats. In particular
they studied the age-related changes in distribution of GRK sub-
types 2, 3, or 5 and β-arrestin (cytoplasmic vs. crude membrane
preparations), and demonstrated that GRKs are implicated in the
reduction of β-AR-mediated vasorelaxation with advancing age,
suggesting a strong evidence that increased GRK activity plays an
important role in cardiovascular physiology of aging. However, it
is important to underline that in this study was not performed
detection of GRKs in the heart tissues as it was performed in the
previous studies mentioned above, explaining this controversial
results. On this basis Leosco et al. (2003), studying the effects
of exercise, found a reduced β-AR expression in aged rat carotid
arteries, and the exercise itself restored the age-associated blunted
β-AR responsiveness. This could explain with the age-related
reduced adaptation of cardiovascular system to different stressors.
For the first time Leinweber et al. (2003) studied the possi-
ble GRKs activity alterations related to aging in humans. The
study evaluated the cytosolic and membranous levels of GRKs in
right atria from children with congenital heart disease undergo-
ing cardiac surgery, elderly with coronary heart disease but not
suffering from heart failure undergoing coronary artery by-pass
grafting, and from a small group of elderly patients with heart
failure also undergoing cardiac surgery. The main result was that
neither cytosolic nor membranous GRKs activity were modified
in elderly compared to children, while, as confirmed in previ-
ous studies (Ungerer et al., 1993; Ping et al., 1997; Vinge et al.,
2001; Rockman et al., 2002; Iaccarino et al., 2005) there was a
notable up-regulation in the GRKs activity in the failing heart.
The reason because the β-AR desensitization in the aging heart
is not associated to GRKs up-regulation is not well clarified at
present. It can be hypothesized that the GRKs levels are more
affected by acute triggers as in heart failure happens and not
influenced by a gradual chronic “aging” process of β-adrenergic
drive, or at least during this life-long process GRKs levels are
associated to other adaptive mechanism that may influence their
up-regulation. In Table 1 the main general age-related changes in
β-adrenergic signaling are described.
CLINICAL IMPLICATIONS OF ALTERATIONS IN
β-ADRENOCEPTOR MECHANISMS IN THE AGING HEART.
RELATIONSHIP WITH HEART FAILURE
Heart failure and associated clinical implication induced by
alterations in β-adrenoceptor mechanisms are a central problem
for elderly population (Ferrara et al., 1997b). Epidemiological
studies showed high prevalence and incidence of heart failure
in the elderly (Corbi et al., 2008; Roger et al., 2011) due also to
an increased longevity. The incidence doubles with each decade
of life and prevalence rises almost 10% of those older than 80
years (Cacciatore et al., 1998). About 50% of all heart failure
cases is found in patients older than 70 (Roger et al., 2011).
Although nowadays an important decrease in the mortality for
heart disease, cardiovascular disease is the most frequent single
cause of death in the elderly population. The prognosis of heart
failure among elderly is poor with a 4 year survival of only
around 50% (Cacciatore et al., 1998) heart failure is also one of
the most important causes of comorbidity and hospitalization
rising health costs.
It is important to underline that heart failure in the elderly
appears when cardiovascular structural and functional age-
related changes are already evident. Moreover, the age-associated
changes in cardiovascular structure/function are involved in the
increased risk for heart failure in older people. An age-dependent
increase in left ventricular wall thickness in men and woman
without hypertension has been described in the Framingham
Heart Study and Baltimore Longitudinal Study on Aging (Ho
et al., 1993). These modifications in structure of heart are char-
acterized by an increase in cardiomyocyte size and myocardial
thickness modifying the contractile efficiency and increasing left
ventricular mass (Olivetti et al., 1991; Khouri et al., 2005). As a
result of age-related chronic stress, the myocardium can undergo
cardiomyocyte death including necrosis, apoptosis or autophagy.
This process induces initially a compensatory remodeling charac-
terized by the alterations of extracellular matrix (ECM) compo-
sition involving the synthesis of myofibroblasts, the degradation
of collagen through TGF-B signaling. These alterations lead to the
hypertrophy of the remaining cells and to pathologic remodeling,
with consequent reactive fibrosis that increases cardiac stiffness
and reduces the cardiac compliance (Boyle et al., 2011).
It has been reported that the process of cardiac aging, as
well as the progressive heart failure, is also characterized by the
impaired Ca++ reuptake and the decreased SR Ca++ storage. In
some studies this decline has been explained by the modification
of SERCA2 protein. This impaired Ca++ reuptake is responsi-
ble for the delays in the ventricular relaxation (Sucharov et al.,
2006). The myocardial remodeling, myocardial stiffening and the
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Table 1 | Cardiovascular system: the main general age-related changes in β-adrenergic signaling.
Author Constituent Species Changes
Abrass and Scapace, 1981 β-AR density Human (circulating lymphocytes) Unchanged
Landmann et al., 1981 β-AR density Human (circulating lymphocytes) Unchanged
Gudmundsdottir et al., 1991 β-AR density Rat (heart) Decreased
Bohm et al., 1993 β-AR density Rat (heart) Unchanged
Bohm et al., 1993 Gi content Rat (heart) Increased
White et al., 1994 β1-AR density Human (heart) Decreased
Bazan et al., 1994 β-AR density Rat (heart) Unchanged
Cerbai et al., 1995 β-AR density Rat (heart) Decreased
Ferrara et al., 1995 β-AR density Guinea-pig (heart) Decreased
Ferrara et al., 1997a,b Gi content Guinea-pig (heart) Unchanged
Ferrara et al., 1997a,b Gi activity Giunea-pig (heart) Increased
Xiao et al., 1998 β1, 2-AR density Rat (heart) Decreased
Xiao et al., 1998 Gi activity Rat (heart) Unchanged
Schutzer et al., 2001 β-AR Rat (aorta) Decreased
Schutzer et al., 2001 GRK2, GRK3, β-arrestin Rat (aorta) Increased
Leinweber et al., 2003 GRK Human (heart) Unchanged
delayed ventricular relaxation compromise the left ventricular
filling in early diastole. In order to maintain an adequate left
ventricular filling in elderly the atrial contraction (A wave) is fur-
ther increased leading to the atrial hypertrophy increasing so the
risk for atrial fibrillation. However, these data have not been con-
firmed utilizing other epidemiological and autopsy-based studies
(?) in subjects free from coronary artery disease and hypertension.
In fact, these studies have demonstrated no significant changes in
cardiac mass in women and a decrease in left ventricular mass
in men. Based on these and other studies it has been shown
that there is no significant changes in left ventricular mass in the
elderly women, but there is a reduction of cardiac mass in men
(cardiac sarcopenia). Regarding to this Lin et al. (2008) demon-
strated, combining experimental and mathematical models, in
mice an age-related cardiac sarcopenia and that LV remodeling
due to increased end diastolic pressure could be an underly-
ing mechanism for age-related LV dysfunction. Senescence is
characterized by a reduction of myocytes cell number. In order
to maintain the cardiac function, some compensatory mecha-
nisms are induced such as: increase of individual myoctye size,
increase of intracellular glycogen storage and reactive fibrosis.
This changes induce a depressed cardiac function in elderly.
Moreover, asymmetric increase in the intraventricular septum
does not influence the total cardiac mass. Nevertheless these
changes do not modify significantly the systolic cardiac function
at rest as demonstrated by echocardiographic and radionuclide
studies in normotensive healthy population (Hess et al., 2002;
Khouri et al., 2005). Instead the pattern of diastolic function
changes with aging and plays a pivotal role in increased prevalence
of diastolic heart failure in the elderly. There are many similarities
between the aging and failing heart. For example, morpholog-
ically myocytes hypertrophy and cardiac fibrosis occur in both
aging and failing heart that exhibit decreased diastolic function
and increased ventricular mass. In both there is a decreased func-
tional reserve and defective cardiac energetics. The age-related
changes in β-AR behavior are quite similar to those related to
failing heart and these changes may be induced by the compen-
satory adrenergic drive activation. The stimulation of adrenergic
receptors by catecholamines is the most important regulatory
mechanism for cardiovascular performance. It is well known that
the levels of cathecolamines are directly correlated with mortal-
ity and functional class of heart failure (Cohn et al., 1984). The
cardiac β-receptors, in particular the β1 subtype, are downreg-
ulated in heart failure and the heart failure-associated reduced
cardiac adrenergic responsiveness are related to an increase in
Gαi activity and in activity of the adrenoreceptor kinases. Failing
heart-associated β-AR down-regulation seems to effect the β1-AR
but not the β2-AR density and this abnormality is also related
to GRK2 and Gi up-regulation (Bristow et al., 1986). Physical
performance as well as other stressors stimulate the adrenergic
system increasing heart rate, myocardial contractility and relax-
ation, reducing left ventricular afterload and redistributing blood
to working muscle. As above described, this pattern modifies
during aging. A possible explanation of this behavior is in rela-
tionship with the chronic and gradual sympathetic hyperactivity.
The association of failing to aging heart physiologic changes is
not important only for the worldwide health care system but
also for explaining the worst of quality of life in these patients.
For these reasons since about 30 years the research studies about
the relationship between adrenergic system and heart failure are
interestingly increasing. In the early 1982, Bristow et al. (1982)
studying the myocardium contractility “in vivo,” examined the
β-AR pathway in failing hearts obtained from human subjects
undergoing cardiac-transplantation. It was noticed an important
reduction in the contractile response to isoproterenol in these
“in vivo” cardiac cells and also an evident reduction of the β-
AR density. The same author (Bristow et al., 1986) after a couple
of years, developed a radiolig and biopsy method for identify-
ing β-AR in human ventricular myocardium. This method it is
thought to be useful in the direct analyses in the β-AR density
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and in the study of down-regulation. The development of this
new method opened a new window in the molecular pharma-
cology of adrenergic system. Brodde et al. (1989) concluded that
the β-AR density level reduction is associated to the severity
of congestive heart failure, and in valvular heart failure exist a
decrease in either β1-AR and β2-AR density. β-AR desensitiza-
tion in the failing heart is proved from many authors, but this
is not the one and only mechanism involved in a complex disease
like heart failure. Feldman et al. (1988) observed the increased
activity of α G40 complex in the human failing heart and con-
sidered as a possible new marker for the severity of failing heart.
Fu et al. (1992) also concluded that the role of Gi protein is
crucial in the failing heart but it was observed an increase in
functional activity rather than in its amount. In 1997 Ping et al.
(1997) during the pacing induced congestive heart failure (CHF)
examined the alteration of β-ARs, AC activity and GRKs. They
concluded that in the advanced stages of CHF, β-ARs and AC
are down-regulated while there is an increase in the GRKs lev-
els since the early stages of CHF. Ungerer et al. (1993) studying
the involvement of β-AR in human heart failure models found
for the first time an inverse correlation between β-AR density
and β-ARKs. The β-AR density is reduced but also the remaining
receptors are less effective. Initially the catecholamines released
from sympathetic nerves try to restore the cardiac functioning
by acting on the β-AR. In long term the enhanced sympa-
thetic drive causes the β-AR desensitization, At least part of
this adaptative mechanism should protect heart from further
sympathetic activation, but the overall cardiac performance is
depressed.
The genetic engineering and the need to establish a quite sim-
ilar model of human disease have driven the scientific research
to develop transgenic animal models. These model are produced
by using DNA microinjections in animals or by using another
methodology like the gene knock-out models. In 1996 Rockman
et al. (1996) in order to investigate the β-AR alteration and con-
tribution in heart failure, used a model of transgenic mice with
overexpression of β-ARK1 inhibitors or β2-AR overexpression.
It resulted that overexpressed β-ARK1 inhibitors increased the
myocardial contractility and prevented the development of heart
failure. A couple of years later Harding et al. (2001) developed
a transgenic mice model overexpressing β-ARK1 inhibitor (β-
ARK1CT) and calsequestrin protein. In this model a treatment
with β-blockers led to an improvement of cardiac contractile
functioning and an longer survival.
The development of animal surgery techniques also helped to
obtain similar rat models of heart failure. Vinge et al. (2001) stud-
ied the involvement of GRKs in postinfarction heart failure model
in rats undergoing ligation of left coronary artery. They concluded
that GRK2 and β-arrestin1 are primary regulators in the endothe-
lial function in the heart failure, while the GRK3 and GRK5 play
a very important role in the cardiac myocyte functioning. The
increased levels of GRK2was related to the infarction induction
suggesting that this protein may precipitate the development of
acute heart failure. Iaccarino et al. (2005) found an inverse corre-
lation between the β-ARs expression and the levels of GRK2. This
inverse correlation can be explained by the phsophorylation of
β-ARs by GRKs and furthermore their internalization and desen-
sitization process. Interestingly the level of GRK2is associated to
Table 2 | Failing heart: the main general changes in β-adrenergic signaling.
Author Constituent Species Changes
Bristow et al., 1982 β-AR density Human (heart) Decreased
Bristow et al., 1986 β1-AR density Human (heart) Decreased
Brodde et al., 1989 β1, 2-AR density Human (heart Decreased
Feldman et al., 1988 α G40 activity Human (heart) Increased
Ungerer et al., 1993 β-ARK Human (heart) Up-regulated
Fu et al., 1992 Gi Human (heart) Increased
Ping et al., 1997 β-AR Human (heart) Down-regulated
Ping et al., 1997 AC Human (heart) Down-regulated
Ping et al., 1997 GRKs Human (heart) Increased
Rockman et al., 1996 β-ARK1 Inhibitors (overexpression) Transgenic mouse (heart) Increased contractility
Harding et al., 2001 β-ARKct (overexpression) Transgenic mouse (heart) Increased contractility
Vinge et al., 2001 β-ARRESTIN1 Rat (heart) Increased
Vinge et al., 2001 GRK2 Rat (heart) Increased
Vinge et al., 2001 GRK5 Rat (heart) Increased
Iaccarino et al., 2005 GRK2 Human (heart) Up-regulated
Lymperopoulos et al., 2007 α2-AR Rat (adrenal medulla) Down-regulated
Lymperopoulos et al., 2007 α2-AR Transgenic mouse (adrenal medulla) Down-regulated
Lymperopoulos et al., 2007 GRK2 Rat (adrenal medulla) Up-regulated
Lymperopoulos et al., 2007 GRK2 Transgenic mouse (adrenal medulla) Up-regulated
Rengo et al., 2012a,b,c α2-AR density Rat (adrenal medulla) Down-regulated
Rengo et al., 2012a,b,c GRK2 Rat (adrenal medulla) Increased
Rengo et al., 2014 GRK2 Human (lymphocytes) Increase
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the degree of heart failure, suggesting an importance of GRKs as
a heart failure progression biomarker. In 2007, for the first time,
Lymperopoulos et al. (2007) studied the involvement of adrenal
signaling in the pathophysiology of heart failure. The study was
performed in two different models, in transgenic mice with car-
diac overexpression of SR calcium binding protein calsequestrin
(CSQ) and rat model undergoing myocardial infarction. It was
noticed an α2-AR down-regulation independent of species and a
GRK2 up-regulation. In 2012, in a post-infarction heart failure rat
model Rengo et al. (2012b) studied the influence of adrenergic
blockade in the in GRK2 and α2-AR adrenal medulla dysregu-
lation. It has been confirmed that there is an up-regulation of
adrenal medulla GRK2 and a down-regulation of α2-AR and that
their blockade with β-blockers normalizes the level of GRK2. The
same author (Rengo et al., 2012c) in 2012 investigated the role
of β2-AR in a post-myocardial infarction heart failure rat model.
This model underwent an adenoviral-mediated overexpression of
β2-AR after 4 weeks of surgery procedure. It was observed that the
overexpression of β2-AR improves the angiogenesis process and
enhanced the coronary reserve and myocardial blood flow. This
pro-angiogenic characteristic of β2-AR was associated to the acti-
vation of pro-angiogenic vascular endothelial growth factor, pro-
tein kinase B, endothelial nitric oxide synthase VEGF/PKB/eNOS
pathway.
Recently returning to the well-known method of detection
GRKs levels from the lymphocytes, Rengo et al. (2014) performed
a prospective study in a group of heart failure patients who
underwent exercise training. It was shown for the first time that
the subjects after physical performance presented reduced levels
of GRKs and also predicted survival. In Table 2 the main gen-
eral failing heart-related changes in β-adrenergic signaling are
described.
CONCLUSIONS
Cardiovascular diseases are the most common cause of death
in elderly population. Increased longevity is associated to an
increased heart failure morbidity with poor prognosis among
elderly. For this reasons it is very important to understand
and clarify the pathophysiological mechanisms that underlay
the aging heart process. From the present literature it seems
that “β-adrenoceptor desensitization/down-regulation” is a gen-
eral and common mechanism which explains age- and heart
failure-related decrease in β-adrenoceptor response to agonists.
In particular, in both aging and failing hearts the decrease in β-
adrenoceptor responsiveness is related to changes in G-proteins
and kinases activity, although there are differences in the level and
the extent of these changes among different studied species. These
molecular alterations are responsible for the most structural and
functional changes in aging heart. The improved understanding
of this mechanism could help in the future to develop new therapy
approach and ameliorate life quality among elderly population.
REFERENCES
Abrass, I. B., and Scapace, P. J. (1981). Human lymphocytes β-adrenergic receptors
are unaltered with age. J. Gerontol. 36, 298–301. doi: 10.1093/geronj/36.3.298
Alquist, R. F. (1948). A study of the adrenotropic receptors. Am. J. Physiol. 153,
586–600.
Altschuld, R. A., Starling, R. C., Hamlin, R. L., Billman, G. E., Hensley,
J., Castillo, L., et al. (1995). Response of failing canine and human
heart cells to β2-adrenergic stimulation. Circulation 92, 1612–1618. doi:
10.1161/01.CIR.92.6.1612
Bazan, A., Van de Velde, E., and Fraeyman, N. (1994). Effects of age on β-
receptors. Gsα- and Giα- proteins in rat heart. Res. Pharmacol. 48, 479–486. doi:
10.1016/0006-2952(94)90277-1
Benovic, J. L., Onorato, J. J., Arriza, J. L., Stone, W. C., Lohse, M., Jenkins, N. A.,
et al. (1991). Cloning, expression and chromosomal localization of β-adrenergic
receptor kinase 2. J. Biol. Chem. 266, 14939–14946.
Bogoyevitch, M. A., Andersson, M. B., Gillespie-Brown, J., Clerck, A., Glennon, P.
E., Fuller, S. J., et al. (1996). Adrenergic receptor stimulation of the mitogen-
activated protein kinase cascade and cardiac hypertrophy. Biochem. J. 314,
115–121.
Bohm, M., Dorner, H., Htun, P., Lensche, H., Platt, D., and Erdmann, E. (1993).
Effects of exercise on myocardial adenylatecyclase and Gi alpha expression in
senescence. Am. J. Physiol. 264, H805–H814.
Borea, P. A., Amerini, S., Masini, I., Cerbai, E., Ledda, F., Mantelli, L., et al. (1992).
β1 and β2− adrenoceptors in sheep cardiac ventricular muscle. J. Mol. Cell.
Cardiol. 24, 753–763. doi: 10.1016/0022-2828(92)93389-2
Boyle, A. J., Shih, H., Hwang, J., Ye, J., Lee, B., Zhang, Y., et al. (2011).
Cardiomyopathy of aging in the mammalian heart is characterized by
myocardial hypertrophy, fibrosis and a predisposition towards cardiomyocyte
apoptosis and autophagy. Exp. Gerontol. 46, 549–559. doi: 10.1016/j.exger.
2011.02.010
Bristow, M. R., Ginsburg, R., Minobe, W., Cubicciotti, R. S., Sageman, W. S.,
Lurie, K., et al. (1982). Decreased catecholamine sensitivity and β-adrenergic-
receptor density in failing human hearts. N. Engl. J. Med. 307, 205–211. doi:
10.1056/NEJM198207223070401
Bristow, M. R., Ginsburg, R., Umans, V., Fowler, M., Minobe, W., Rasmussen, R.,
et al. (1986). β1 and β2-adrenergic-receptor subpopulations in non failing and
failing human ventricular myocardium: coupling of both receptorsubtypes to
muscle contraction and selective β1-receptor downregulation in heart failure.
Circ. Res. 59, 297–309. doi: 10.1161/01.RES.59.3.297
Brodde, O. E., Zerkowski, H. R., Doetsch, N., Motomura, S., Khamssi, M., and
Michel, M. C. (1989). Myocardial β-adrenoceptor changes in heart failure: con-
comitant reduction in β1- and β2-adrenoceptor function related to the degree
of heart failure in patients with mitral valve disease. J. Am. Coll. Cardiol. 14,
323–331. doi: 10.1016/0735-1097(89)90181-2
Buxton, L. O., and Bruton, L. L. (1985). Direct analyses of β-adrenergic receptor
subtype in intact adult ventricular myocytes of the rats. Circ. Res. 56, 126–132.
doi: 10.1161/01.RES.56.1.126
Cacciatore, F., Gallo, C., Ferrara, N., Abete, P., Paolisso, G., Canonico, S.,
et al. (1998). Morbidity patterns in aged population in southern Italy. A
survey sampling. Arch. Gerontol. Geriatr. 26, 201–213. doi: 10.1016/S0167-
4943(98)00003-X
Cannavo, A., Rengo, G., Liccardo, D., Pironti, G., Scimia, M. C., Scudiero, L.,
et al. (2013). Prothymosin alpha protects cardiomyocytes againts ischemia-
induced apoptosis via presentation of Act activation. Apoptosis.18, 1252–1261.
doi: 10.1007/s10495-013-0876-9
Cerbai, E., Varani, K., Barbieri, M., Borea, P. A., and Mugelli, A. (1995). β-
adrenoreceptor subtypes in young and old rat ventricular myocytes. A com-
bined patch-clamp and binding study. Br. J. Pharmacol. 116, 1835–1842. doi:
10.1111/j.1476-5381.1995.tb16671.x
Cohn, J. N., Levine, T. B., Olivari, M. T., Garberg, V., Lura, D., and Francis, G.
S., et al. (1984). Plasma norepinephrine as a guide to prognosis in patients
with chronic congestive heart failure. N. Engl. J. Med. 311, 819–823. doi:
10.1056/NEJM198409273111303
Corbi, G., Acanfora, D., Iannuzzi, G. L., Longobardi, G., Cacciatore, F., Furgi, G.,
et al. (2008). Hypermagnesemia predicts mortality in elderly with congestive
heart disease: relationship with laxative and antacid use. Rejuvenat. Res. 11,
129–138. doi: 10.1089/rej.2007.0583
Corbi, G., Conti, V., Russomanno, G., Longobardi, G., Furgi, G., Filippelli, A.,
et al. (2013a). Adrenergic signaling and oxidative stress: a role of sirtuins? Front.
Physiol. 4:324. doi: 10.3389/fphys.2013.00324
Corbi, G., Bianoc, A., Turchiarelli, V., Cellurale, M., Fatica, F., Daniele, A., et al.
(2013b). Potential mechanisms linking atherosclerosis and increased cardiovas-
cular risk in COPD: focus on sirtuins. Int. J. Mol. Sci. 14, 12696–12713. doi:
10.3390/ijms140612696
Frontiers in Physiology | Clinical and Translational Physiology January 2014 | Volume 4 | Article 396 | 8
Ferrara et al. Aging heart and β-adrenergic system
Corbi, G., Conti, V., Russomanno, G., Rengo, G., Vitulli, P., Ciccarelli, A. L., et al.
(2012a). Is physical activity able to modify oxidative damage in cardiovascular
aging? Oxid. Med. Cell. Longev. 2012, 728547. doi: 10.1155/2012/728547
Corbi, G., Conti, V., Scapagnini, G., Filippelli, A., and Ferrara, N. (2012b). Role
of sirtuins, calorie restriction and physical activity in aging. Front. Biosci. (Elite.
Ed). 4:417. doi: 10.2741/417
Corbi, G. M., Carbone, S., Ziccardi, P., Giugliano, G., Marfella, R., Nappo, F., et al.
(2002). FFAs and QT intervals in obese women with visceral adiposity: effects
of sustained weight loss over 1 year. J. Clin. Endocrinol. Metab. 87, 2080–2083.
doi: 10.1210/jc.87.5.2080
Davies, C. H., Ferrara, N., and Harding, S. E. (1996). β-Adrenoceptor function
changes with age of subject in myocytes from non-failing human ventricle.
Cardiovasc. Res. 31, 152–156. doi: 10.1016/0008-6363(95)00187-5
Dobson, J. G., Fenton, R. A., and Romano, F. D. (1990). Increased myocardial
adenosine production and reduction of β-adrenergic contractile response in
aged hearts. Cir. Res. 66, 1381–1390. doi: 10.1161/01.RES.66.5.1381
Ehsani, A. A. (1987). Cardiovascular adaptations to exercise training in the elderly.
Fed. Proc. 46, 1840–1843.
Enns, L. C., Morton, J. F., Treuting, P. R., Edmond, M. J., Wolf, N. S., Dai, D. F.,
et al. (2009). Disruption of protein kinase A in mice enhances healthy aging.
PLoS ONE 4:e5963. doi: 10.1371/journal.pone.0005963
Esler, M. D., Turner, A. G., Kaye, A. G., Thompson, J. M., Kingwell, B. A., Morris,
M., et al. (1995). Aging effects on human sympathetic neuronal function. Am.
J. Physiol. 268(1 Pt), R278–R285.
Feldman, A. M., Cates, A. E., Veazey, W. B., Hershberger, R. E., Bristow, M. R.,
Baughman, K. L., et al. (1988). Increase of the 40,000-mol wt pertussis toxin
substrate (G protein) in the failing human heart. J. Clin. Invest. 82, 189–197.
doi: 10.1172/JCI113569
Ferrara, N., Abete, P., Corbi, G., Paolisso, G., Longobardi, G., Calabrese, C., et al.
(2005). Insulin-induced changes in β-adrenergic response: an experimental
study in the isolated rat papillary muscle. Am. J. Hypertens. 18, 348–353. doi:
10.1016/j.amjhyper.2004.10.006
Ferrara, N., Bohm, M., Zolk, O., O’Gara, P., and Harding, S. E. (1997a). The
role of Gi-proteins and β-adrenoceptors in the age-related decline of contrac-
tion in guinea-pig ventricular myocytes. J. Mol. Cell. Cardiol. 29, 439–448. doi:
10.1006/jmcc.1996.0397
Ferrara, N., Davia, K., Abete, P., Rengo, F., andHarding, S. E. (1997b). Alterations in
β-adrenoceptor mechanisms in the aging heart. Relationship with heart failure.
Aging (Milano). 9, 391–403.
Ferrara, N., Corbi, G., Bosimini, E., Cobelli, F., Furgi, G., Giannuzzi, P., et al. (2006).
Cardiac rehabilitation in the elderly: patient selection and outcomes. Am. J.
Geriatr. Cardiol. 15, 22–27. doi: 10.1111/j.1076-7460.2006.05289.x
Ferrara, N., O’Gara, P., Wynne, D. G., Brown, L. A., del Monte, F., Poole-Wilson,
P. A., et al. (1995). Decreased contractile responses to isoproterenol in isolated
cardiac myocytes from aging guinea-pigs. J. Mol. Cell. Cardiol. 27, 1141–1150.
doi: 10.1016/0022-2828(95)90050-0
Fleg, J. L., Schulman, S., O’Connor, F., Becker, L. C., Gerstenblith, G., Clulow, J. F.,
et al. (1994). Effects of acute β-adrenergic receptor blockade on age associated
changes in cardiovascular performance during dynamic exercise. Circulation 90,
2333–2341. doi: 10.1161/01.CIR.90.5.2333
Folkow, B., and Svanborg, A. (1993). Physiology of cardiovascular aging. Physiol.
Rev. 73, 725–764.
Freedman, N. J., Liggett, S. B., Drachman, D. E., Pei, G., Caron, M. G., and
Lefkowtiz, R. J. (1995). Phosphorylation and desensitization of the human β1-
adrenergic receptor: involvement of G protein coupled receptor kinase and
cAMP dependent protein kinase. J. Biol. Chem. 270, 17953–17961.
Froehlich, J. P., Lakatta, E. G., Beard, E., Spurgeon, H. A., Weisfeldt, M. L., and
Gerstenbilth, G. (1978). Studies of sarcoplasmic reticulum function and con-
traction duration in young and aged rat myocardium. J. Mol. Cell. Cardiol. 10,
427–438. doi: 10.1016/0022-2828(78)90364-4
Fu, L. X., Liang, Q. M., Waagstein, F., Hoebeke, J., Sylvén, C., Jansson, E., et al.
(1992). Increase in functional activity rather than in amount of Gi-alpha in fail-
ing human heart with dilated cardiomyopathy. Cardiovasc. Res. 26, 950–955.
doi: 10.1093/cvr/26.10.950
Gudmundsdottir, E., Benediktsdottir, V. E., and Gudbjarnason, S. (1991).
Combined effects of age and dietary fat on β-1 receptors and Ca2+ channels
in rat hearts. Am. J. Physiol. 260(1 Pt 2), H66–H72.
Hall, R. A., Premont, R. T., Chow, C. W., Blitzer, J. T., Pitcher, J. A.,
Claing, A., et al. (1998). The β2-adrenergic receptor interacts with the
Na+/H+-exchanger regulatory factor to control Na+/H+ exchange.Nature 392,
626–630. doi:10.1038/33458
Harding, V. B., Jones, L. R., Lefkowitz, R. J., Koch, W. J., and Rockman, H. A.
(2001). Cardiac βARK1 inhibition prolongs survival and augments β-blocker
therapy in a mouse model of severe heart failure. Proc. Natl. Acad. Sci. U.S.A.
98, 5809–5814. doi: 10.1073/pnas.091102398
Hess, P. S., Fleg, J., Lakatta, E. G., and Shapiro, E. P. (2002). Left ventricular
remodeling with age in normal men versus women: novel insights using three-
dimensional magnetic resonance imaging. Am. J. Cardiol. 90, 1231–1236. doi:
10.1016/S0002-9149(02)02840-0
Ho, K. K., Pinsky, J. L., Kannel, W. B., and Levy, D. (1993). The epidemiology
of heart failure: the Framingham study. J. Am. Coll. Cardiol. 22(4 Suppl. A),
6A–13A. doi: 10.1016/0735-1097(93)90455-A
Iaccarino, G., Barbato, E., Cipolletta, E., De Amicis, V., Margulies, K. B., Leosco,
D., et al. (2005). Elevated myocardial and lymphocyte GRK2 expression and
activity in human heart failure. Eur. Heart J. 17, 1752–1758. doi: 10.1093/eur-
heartj/ehi429
Jiang, M. T., Moffat, M. P., and Narayanan, N. (1993). Age-related alterations in
the phosphorylation of sarcoplasmic reticulum and myofibrillar proteins and
diminished contractile response to isoproterenol in intact rat ventricle.Circ. Res.
72, 102–111. doi: 10.1161/01.RES.72.1.102
Khouri, M. G., Maurer, M. S., and El-Khoury Rumbarger, L. (2005). Assessment of
age-related changes in left ventricular structure by freehand three-dimensional
echocardiography. Am. J. Geriatr. Cardiol. 14, 118–125. doi: 10.1111/j.1076-
7460.2005.03845.x
Kuschel, M., Zhou, Y. Y., Spurgeon, H. A., Bartel, S., Karchewski, P., Zhang, S. J.,
et al. (1999). β2-Adrenergic cAMP signaling is uncoupled from phosphoryla-
tion of cytoplasmic proteins in canine heart. Circulation. 99, 2458–2465. doi:
10.1161/01.CIR.99.18.2458
Lakatta, E. G., and Levy, D. (2003). Arterial and cardiac aging: major
shareholders in cardiovascular disease enterprises: part II: the aging
heart in health: links to heart disease. Circulation 107, 346–354. doi:
10.1161/01.CIR.0000048893.62841.F7
Landmann, R., Bittinger, H., and Buhler, F. R. (1981). High affinity β2-adrenergic
receptors in mononuclear leucocytes: similar density in young and old normal
subjects. Life Sci. 29, 1761–1771. doi: 10.1016/0024-3205(81)90186-7
Leineweber, K., Wangemann, T., Giessler, C., Bruck, H., Dhein, S., Kostelka, M.,
et al. (2002). Age-dependent changes of cardiac neuronal noradrenaline reup-
take transporter (uptake1) in human heart. Am. Coll. Cardiol. 40, 1459–1465.
doi: 10.1016/S0735-1097(02)02168-X
Leinweber, K., Klapproth, S., Beilfuss, A., Silber, R. E., Heusch, G., Philipp, T.,
et al. (2003). Unchanged G-protein-coupled receptor kinase activity in the
aging human heart. J. Am. Col. Cardiol. 42, 1487–1492. doi: 10.1016/S0735-
1097(03)01063-5
Lemoine, H., and Kaumann, A. J. (1991). Regional differences of β1- and β2-
adrenoceptor-mediated functions in feline heart: a β-adrenoceptormediated
positive inotropic effect possibly unrelated to cyclic AMP. Naunyn
Schmiedebergs. Arch. Pharmacol. 344, 56–59.
Leosco, D., Iaccarino, G., Cipolletta, E., De Santis, D., Pisani, E., Trimarco, V.,
et al. (2003). Exercise restores β-adrenergic vasorelaxation in aged rat carotid
arteries. Am. J. Physiol. Heart. Circ. Physiol. 285, 369–374. doi: 10.1152/ajp-
heart.00019.2003
Leosco, D., Rengo, G., Iaccarino, G., Filippelli, A., Lymperopoulos, A., Zincarelli,
C., et al. (2007). Exercise training and β-blocker treatment ameliorate age-
dependent impairment of β-adrenergic receptor signaling and enhance car-
diac responsiveness to adrenergic stimulation. Am. J. Physiol. Heart Circ. 293,
H1596–H1603. doi: 10.1152/ajpheart.00308.2007
Lewis, C. J., Haibin, G., Brown, M. J., and Harding, S. E. (2004). Overexpression
of β1-adrenoceptors in adult rat ventricular myocytes enhances CGP 12177A
cardiostimulation: implications for “putative” β4-adrenoceptor pharmacology.
Br. J. Pharmacol. 141, 813–824. doi: 10.1038/sj.bjp.0705668
Lin, J., Lopez, E. F., Jin, Y., Van Remmen, H., Bauch, T., Han, H. C., et al. (2008).
Age-related cardiac muscle sarcopenia: combining experimental and mathe-
matical modeling to identify mechanisms. Exp. Gerontol. 43, 296–306. doi:
10.1016/j.exger.2007.12.005
Lonardo, G., Cerbai, E., Casini, S., Giunti, G., Bonacchi, M., Battaglia, F., et al.
(2005). Pharmacological modulation of the hyperpolarization-activated current
(I f) in human atrial myocytes: focus on G protein-coupled receptors. J. Mol.
Cell. Cardiol. 38, 453–460. doi: 10.1016/j.yjmcc.2004.12.010
www.frontiersin.org January 2014 | Volume 4 | Article 396 | 9
Ferrara et al. Aging heart and β-adrenergic system
Lymperopoulos, A., Rengo, G., Funakoshi, H., Eckhart, A. D., and Koch, W. J.
(2007). Adrenal GRK2 mediates sympathetic overdrive in heart failure. Nat.
Med. 13, 315–323. doi: 10.1038/nm1553
Marshall, C. J. (1995). Specificity of receptor tyrosine kinase signaling: tran-
sient versus sustained extracellular signal-regulated kinase activation. Cell 80,
179–185. doi: 10.1016/0092-8674(95)90401-8
McConnachie, G., Langeberg, L. K., and Scott, J. D. (2006). AKAP signaling com-
plexes: getting to the heart of the matter. Trends Mol. Med. 12, 317–323. doi:
10.1016/j.molmed.2006.05.008
Morisco, C., Zebrowski, D., Condorelli, G., Tsichlis, P., Vatner, S. F., and Sadoshima,
J. (2000). The Akt-glycogen synthase kinase 3β pathway regulates transcription
of atrial natriuretic factor induced by β-adrenergic receptor stimulation in car-
diac myocytes. J. Biol. Chem. 275, 14466–14475. doi: 10.1074/jbc.275.19.14466
Ng, A. V., Callister, D. G., Johnson, D. G., and Seals, D. R. (1993). Age and gen-
der influence muscle sympathetic nerve activity at rest in healthy humans.
Hypertension. 21, 498–503. doi: 10.1161/01.HYP.21.4.498
Olivetti, G., Melissari, M., Capasso, J. M., and Anversa, P. (1991). Cadiomyopathy
of aging human heart. Myocyte loss reactive cellular hypertrophy. Circ. Res. 68,
1560–1568. doi: 10.1161/01.RES.68.6.1560
Ping, P., Anzai, T., Gao, M., and Hammond, H. K. (1997). Adenyl cyclase and G
protein receptor kinase expression during development of heart failure. Am. J.
Physiol. 273(2 Pt 2), H707–H717.
Ramirez, M. T., Zhao, X. L., Schulman, H., and Brown, J. H. (1997). The nuclear
δB isoform of Ca2+/calmodulin-dependent protein kinase regulates atrial natri-
uretic factor gene expression in ventricular myocytes. J. Biol. Chem. 272,
31203–31208. doi: 10.1074/jbc.272.49.31203
Rengo, G., Galasso, G., Femminella, G. D., Parisi, V., Zincarelli, C., Pagano, G., et al.
(2014). Reduction of lymphocyte G protein-coupled receptor kinase-2 (GRK2)
after exercise training predicts survival in patients with heart failure. Eur. J. Prev.
Cardiol. 21, 4–11. doi: 10.1177/2047487313491656
Rengo, G., Perrone-Filardi, P., Femminella, G. D., Liccardo, D., Zincarelli,
C., de Lucia, C., et al. (2012a). Targeting the β-adrenergic receptor sys-
tem through G-protein coupled receptor kinase 2: a new paradigm from
therapy and prognostic evaluation in heart failure: from bench to bed-
side. Circ. Heart Fail. 5, 358–391. doi: 10.1161/CIRCHEARTFAILURE.112.
966895
Rengo, G., Lymperopoulos, A., Zincarelli, C., Femminella, G., Liccardo, D., Pagano,
G., et al. (2012b). Blockade of β-adrenoceptors restores the GRK2-mediated
adrenal α2-adrenoceptor-catecholamine production axis in heart failure. Br. J.
Pharmacol. 166, 2430–2440. doi: 10.1111/j.1476-5381.2012.01972.x
Rengo, G., Zincarelli, C., Femminella, G. D., Liccardo, D., Pagano, G., de Lucia, C.,
et al. (2012c). Myocardial β2-adrenoceptor gene delivery promotes coordinated
cardiac adaptive remodelling and angiogenesis in heart failure. Br. J. Pharmacol.
166, 2348–2361. doi: 10.1111/j.1476-5381.2012.01954.x
Rinaldi, B., Corbi, G., Boccuti, S., Filippelli, W., Rengo, G., Leosco, D., et al.
(2006). Exercise training affects age-induced changes in SOD and heat
shock protein expression in rat heart. Exp. Gerontol. 41, 764–770. doi:
10.1016/j.exger.2006.05.008
Rockman, H. A., Koch, W. J., and Lefkowitz, R. J. (2002). Seven-transmembrane-
spanning receptors and heart function. Nature 415, 206–212. doi:
10.1038/415206a
Rockman, H. A., Koch, W. J., Milano C. A., and Lefkowitz, R. J. (1996). Myocardial
β-adrenergic receptor signaling “in vivo”: insights from transgenic mice. J. Mol.
Med. (Berl.) 74, 489–495. doi: 10.1007/BF00204974
Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W.
B., et al. (2011). Executive summary: heart disease and stroke statistics—2011
update: a report from the american heart association. Circulation 123, 459–463.
doi: 10.1161/CIR.0b013e3182009701
Scarpace, P. J., Shu, Y., and Tumer, N. (1994). Influence of exercise training
on myocardial-adrenergic signal transduction: differential regulation with age.
J. Appl. Physiol. 77, 737–741.
Scholtz, D. G., Kitzman, D. W., Hagen, P. T., Ilstrup, D. M., and Edwards, W.
D. (1988). Age-related changes in normal human hearts during the first 10
decades of life. Part I (Growth): a quantitative anatomic study of 200 speci-
mens from subjects from birth to 19 years old. Mayo Clin. Proc. 63, 126–136.
doi: 10.1016/S0025-6196(12)64945-3
Schutzer, W. E., Reed, J. F., Bliziotes, M., and Mader, S. L. (2001). Up-regulation of
G protein-linked receptor kinases with advancing age in rat aorta.Am. J. Physiol.
Regul. Integr. Comp. Physiol. 280, R897–R903.
Shioi, T., and Inuzuka, Y. (2012). Aging as a substrate of heart failure. J. Cardiol. 60,
423–428. doi: 10.1016/j.jjcc.2012.07.015
Spindler, M. J., Burmeister, B. T., Huang, Y., Hsiao, E. C., Salomonis, N., Scott,
M. J., et al. (2013). AKAP13 Rho-GEF and PKD-binding domain deficient
mice develop normally but have an abnormal response to β-adrenergic-induced
cardiac hypertrophy. PLoS ONE 8:e62705. doi: 10.1371/journal.pone.0062705
Sucharov, C. C., Mariner, P. D., Nunley, K. R., Long, C., Leinwand, L., and
Bristow, M. R. (2006). A β1-adrenergic receptor CaM kinase II-dependent path-
way mediates cardiac myocyte fetal gene induction. Am. J. Physiol. Heart Circ.
Physiol. 291, H1299–H1308. doi:10.1152/ajpheart.00017.2006
Ungerer, M., Bohm, M., Elce, J. S., Erdmann, E., and Lohse, M. J. (1993). Altered
expression of β-adrenergic receptor kinase and β1-adrenergic receptors in failing
human heart. Circulation 87, 454–463. doi: 10.1161/01.CIR.87.2.454
Van Biesen, T., Hawes, B. E., Luttrell, D. K., Krueger, K. M., Touhara, K., Porfiri,
E., et al. (1995). Receptor-tyrosine-kinase- and G β gamma-mediated MAP
kinase activation by a common signaling pathway. Nature. 376, 781–784. doi:
10.1038/376781a0
Vinge, L. E., Øie, E., Andersson, Y., Grøgaard, H. K., Andersen, G., and Attramadal,
H. (2001). Myocardial dystribution and regulation of GRK and arrestin iso-
forms in congestive heart failure in rats. Am. J. Physiol. 281, H2490–H2499.
Wang, J., Yang, H., Hu, X., Fu, W., Xie, J., Zhou, X., et al. (2013). Dobutamine-
mediated heme oxygenase-1 induction via PI3K and p38 MAPK inhibits
high mobility group box 1 protein release and attenuates rat myocar-
dial ischemia/reperfusion injury in vivo. J. Surg. Res. 183, 509–516. doi:
10.1016/j.jss.2013.02.051
White, M., Roden, R., Minobe, W., Khan, M. F., Larrabee, P., Wollmering, M.,
et al. (1994). Age- related changes in β-adrenergic neuroeffectors system in the
human heart. Circulation 90, 1225–1238. doi: 10.1161/01.CIR.90.3.1225
Xiao, R. P., Cheng, H., Zhou, Y. Y., Kuschel, M., and Lakatta, E. G. (1999).
Recent Advances in Cardiac β2-Adrenergic Signal Transduction Circ. Res. 85,
1092–1100. doi: 10.1161/01.RES.85.11.1092
Xiao, R. P., Holh, C., Altschuld, R., Jones, L., Livingston, B., Ziman, B., et al.
(1994). β2-adrenergic receptor- stimulated increase in cAMP in rat heart cells
is not coupled to change Ca2+ dynamics, contractility or phospholamban
phosphorylation. J. Biol. Chem. 269, 19151–19156.
Xiao, R. P., Ji, X., and Lakatta, E. G. (1995). Functional coupling of the β2-
adrenoceptor to a pertussis toxin-sensitive G protein in cardiac myocytes. Mol.
Pharmacol. 47, 322–329.
Xiao, R. P., Tomhave, E. D., Wang, D. J., Ji, X., Boluyt, M. O., Cheng, H., et al.
(1998). Age-associated reductions in cardiac β1- and β2-adrenergic responses
without changes in inhibitory G proteins or receptor kinases. J. Clin. Invest.101,
1273–1282. doi: 10.1172/JCI1335
Young, J. B., and Landsberg, L. (1998). “Ch. 17. Catecholamines and the adrenal
medulla,” inWilliams Textbook of Endocrinology, 9th Edn., eds J. D.Wilson, D.W.
Foster, H. M. Kronenberg, and P. R. Larsen (Philadelphia, PA: W.B. Saunders),
665–728.
Zhu, W. Z., Zheng, M., Koch, W. J., Lefkowitz, R. J., Kobilka, B. K., and Xiao, R.
P. (2001). Dual modulation of cell survival and cell death by β2-adrenergic
signaling in adult mouse cardiac myocytes. Proc. Natl. Acad. Sci. U.S.A. 98,
1607–1612. doi: 10.1073/pnas.98.4.1607
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be
construed as a potential conflict of interest.
Received: 28 August 2013; accepted: 17 December 2013; published online: 09 January
2014.
Citation: Ferrara N, Komici K, Corbi G, Pagano G, Furgi G, Rengo C, Femminella
GD, Leosco D and Bonaduce D (2014) β-adrenergic receptor responsiveness in aging
heart and clinical implications. Front. Physiol. 4:396. doi: 10.3389/fphys.2013.00396
This article was submitted to Clinical and Translational Physiology, a section of the
journal Frontiers in Physiology.
Copyright © 2014 Ferrara, Komici, Corbi, Pagano, Furgi, Rengo, Femminella, Leosco
and Bonaduce. This is an open-access article distributed under the terms of the
Creative Commons Attribution License (CC BY). The use, distribution or reproduction
in other forums is permitted, provided the original author(s) or licensor are credited
and that the original publication in this journal is cited, in accordance with accepted
academic practice. No use, distribution or reproduction is permitted which does not
comply with these terms.
Frontiers in Physiology | Clinical and Translational Physiology January 2014 | Volume 4 | Article 396 | 10
